A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Cilofexor in Patients with Non-Cirrhotic Primary Sclerosing Cholangitis (PRIMIS)
JOURNAL OF HEPATOLOGY(2023)
关键词
Primary Sclerosing Cholangitis
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要